Publication:
Stem cell based therapy in the inner ear: Appropriate donor cell types and routes for transplantation

dc.contributor.authorJongkamonwiwat N.
dc.contributor.authorZine A.
dc.contributor.authorRivolta M.N.
dc.date.accessioned2021-04-05T03:36:31Z
dc.date.available2021-04-05T03:36:31Z
dc.date.issued2010
dc.date.issuedBE2553
dc.description.abstractLosing one of our main sensory systems such as hearing can have devastating consequences in the way we interact with the world. The main problem lies in the fact that the critical sensory cells, the auditory neurons and hair cells located in the cochlea are only generated during development and, when damaged, cannot be replaced. The options currently available to treat this condition are very limited, and are mostly represented by prosthetic devices such as hearing aids and cochlear implants. There is a clear need for a therapeutic breakthrough that will help the millions of people affected, and the advances in stem cell technologies are offering a glimmer of hope for this affliction. Although still at a very early stage, a growing bulk of literature is being produced attempting to pave the path for a stem cell-based therapy for deafness. From the many variables to bear in mind when developing this approach, two appear to be of paramount importance. First, different cell types are potentially to be used, all of them having advantages and disadvantages. Second, in order to target such a small and secluded organ as the cochlea, difficult surgical techniques are to be used, some of which still need to be developed. The present article will aim to present the most recent advances of the field, focussing on these two critical issues. © 2010 Bentham Science Publishers Ltd.
dc.format.mimetypeapplication/pdf
dc.identifier.citationCurrent Drug Targets. Vol 11, No.7 (2010), p.888-897
dc.identifier.doi10.2174/138945010791320836
dc.identifier.issn13894501
dc.identifier.other2-s2.0-77954717756
dc.identifier.urihttps://hdl.handle.net/20.500.14740/7561
dc.rights.holderมหาวิทยาลัยศรีนครินทรวิโรฒ
dc.subject.otherCiliary neurotrophic factor
dc.subject.otherDoxycycline
dc.subject.otherNeurogenin 1
dc.subject.otherNeurotrophic factor
dc.subject.otherArticle
dc.subject.otherCell type
dc.subject.otherCochlea duct
dc.subject.otherCochlea prosthesis
dc.subject.otherCochlear nerve
dc.subject.otherCochlear nucleus
dc.subject.otherCorti organ
dc.subject.otherEar protection
dc.subject.otherEmbryonic stem cell
dc.subject.otherHearing impairment
dc.subject.otherHuman
dc.subject.otherInner ear
dc.subject.otherMesenchymal stem cell
dc.subject.otherMesenchymal stem cell transplantation
dc.subject.otherNeural stem cell
dc.subject.otherNonhuman
dc.subject.otherPluripotent stem cell
dc.subject.otherProtein expression
dc.subject.otherSpiral ganglion
dc.subject.otherStem cell transplantation
dc.subject.otherSurgical technique
dc.subject.otherAnimals
dc.subject.otherCochlea
dc.subject.otherCochlear Implantation
dc.subject.otherDeafness
dc.subject.otherHair Cells, Auditory
dc.subject.otherHumans
dc.subject.otherModels, Anatomic
dc.subject.otherNerve Growth Factors
dc.subject.otherRegeneration
dc.subject.otherSensory Receptor Cells
dc.subject.otherStem Cell Transplantation
dc.subject.otherStem Cells
dc.titleStem cell based therapy in the inner ear: Appropriate donor cell types and routes for transplantation
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-77954717756&doi=10.2174%2f138945010791320836&partnerID=40&md5=4496b311412710c79ec3989935da5c6f

Files